Europe Genital Warts Market – Industry Trends and Forecast to 2028

  • Pharmaceutical
  • Published Report
  • Aug 2021
  • Europe
  • 350 Pages
  • No of Tables: 256
  • No of Figures: 53

Europe  Genital warts Market, By Morphology (Cauliflower-Like, Smooth Papular, Keratotic, and Flat Warts), Type (Prevention, Diagnostics, Treatment), Cause (HPV 6, HPV 11, Others), Location (Vulva, Cervix Uteri, Urethra, Anus, Scrotum), Gender (Male and Female), Dosage (Cream, Gel, Ointment, Intramuscularly and Others), End-User (Hospitals, Diagnostic Centers, Surgical Centers, Ambulatory Surgical Centers, and Others), Distribution Channel (Direct Tender, Pharmacy Stores and Others), Country (Germany, France, Italy, Belgium, Spain, Netherlands, Russia, Switzerland, Turkey, Austria, Norway, Hungary, Lithuania, Ireland, Poland, Rest of Europe).

Europe Genital Warts Market Market Analysis and Insights: Europe Genital Warts Market

 Europe genital warts market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses that the market is growing with a CAGR of 6.2% in the forecast period of 2021 to 2028 and is expected to reach USD 2,393.25 million by 2028 from USD 1,519.14 million in 2020. The rising incidence of diabetes and the growth of novel technological advancements for genital warts are likely to be the major drivers which propel the demand of the market in the forecast period.

Genital warts are one of the most recurrent types of sexually transmitted infections. The human papillomavirus is the virus responsible for causing genital warts. People will get infected with at least one type of human papillomavirus (HPV) at some point during their lives. Genital warts affect most of the moist tissues in the genital areas of male and female patients. Although the genital infection is asymptomatic, it's frequently recognized as genital warts due to the onset of symptoms. It is estimated that around 1% of sexually active men and women in the United States have genital warts.

Genital warts are caused due to the human papillomavirus (HPV). There are around 30-40 strains of HPV. However, only a few of the strains cause genital warts. The virus is easily transmittable through skin-to-skin contact. Hence it's considered a sexually transmitted infection (STI). The Center for Disease Control and Prevention (CDC) says that people get genital warts due to the mutant activity of HPV.

The surge in the incidence of sexually transmitted diseases (STDs) and genital warts in Europe, the rise in the patient population, rise in clinical trials for generics and vaccines are expected to drive the Europe genital warts market. Moreover, the increase in government initiatives, rise in healthcare expenditure and strategic initiatives by market players, and huge market potential in developing countries bolsters the genital warts market growth.  However, the increased cost of treatment for genital warts, the side effects noticed while undergoing treatment for genital warts, and lack of patient and consumer awareness are the restraints that could hinder the growth of the genital warts market. The rise in product recalls associated with vaccines, and topical administration of genital warts and patient compliance regarding the use of vaccines are the restraints that could hinder the market growth.

However, a lack of expertise and infrastructure could pose a challenge to the growth of the genital warts market.

The Europe genital warts market report provides details of market share, new developments, and product pipeline analysis, the impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the market scenario, contact us for an Analyst Brief. Our team will help you create a revenue impact solution to achieve your desired goal.  

Europe Genital Warts Market Europe Genital Warts Market Scope and Market Size

Europe genital warts market is segmented on the basis of morphology, type, cause, location, gender, dosage, end-user, and distribution channel.  The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

  • On the basis of morphology, the Europe genital warts market is segmented into flat warts, smooth papular, cauliflower-like, and keratotic. In 2021, the cauliflower-like segment is expected to dominate the genital warts market due to the high prevalence of cauliflower warts in male and female patients.
  • On the basis of type, the Europe genital warts market is segmented into prevention, diagnostics, and treatment. In 2021, the prevention segment is expected to dominate the Europe genital warts market as the prevention is increased due to the availability of preventive vaccines in European pharmacy stores.
  • On the basis of cause, the Europe genital warts market is segmented into HPV 6, HPV 11, and others. In 2021, the HPV 6 segment is expected to dominate the Europe genital warts market owing to the HPV 6 strain having the highest prevalence rate in female patients in Europe.
  • On the basis of location, the Europe genital warts market is segmented into cervix uteri, urethra, anus, vulva, and scrotum. In 2021, the vulva segment is expected to dominate the Europe genital warts market because of the increased number of cases of genital warts in women.
  • On the basis of gender, the Europe genital warts market is segmented into male and female. In 2021, the female segment is expected to dominate the Europe genital warts market due to the higher prevalence or incidence rate and highest cases observed in male patients in Europe.
  • On the basis of dosage, the Europe genital warts market is segmented into cream, gel, ointment, intramuscularly, and others. In 2021, the cream segment is expected to dominate the Europe genital warts market because treatment with cream is the easiest way to treat genital warts and the availability of Galderma in Europe.
  • On the basis of end-users, the Europe genital warts market is segmented into hospitals, diagnostic centers, surgical centers, ambulatory surgical centers, and others. In 2021, the hospital's segment is expected to dominate the Europe genital warts market as hospitals patients have all the facilities, and they could directly contact doctors and increased use of telehealth during the pandemic for better consultation for treatment of genital warts.
  • On the basis of distribution channels, the Europe genital warts market is segmented into direct tender, pharmacy stores, and others. In 2021, the direct tender segment is expected to dominate the Europe genital warts market as there is no requirement of the prescription of doctors and can be purchased and used and rise in competition between e-commerce and direct tenders.

Europe Genital warts Market Country Level Analysis

The Europe genital warts market is analyzed, and market size information is provided by product & services, sample type, process, application, compound library size, end-user, and distribution channel.

The countries covered in the Europe genital warts market report are Germany, France, Italy, Belgium, Spain, Netherlands, Russia, Switzerland, Turkey, Austria, Norway, Hungary, Lithuania, Ireland, Poland, Rest of Europe

Europe is expected to grow with the CAGR in the forecasted periods as in the growing R&D activities in the pharma and biotech sector. Germany is expected to dominate in the market in the Europe genital warts market. Germany is one of the leading countries due to the presence of major market players and increased technological advancement in the region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impact the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts, and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, the presence and availability of European brands and their challenges faced due to large or scarce competition from local and domestic brands, the impact of sales channels are considered while providing forecast analysis of the country data.  

The Growth Potential For Genital Warts In Emerging Economies And The Strategic Initiatives By Market Players Are Creating New Opportunities In The Europe Genital Warts Market 

Europe genital warts market also provides you with detailed market analysis for every country's growth in a particular industry with genital warts sales, the impact of advancement in genital warts, and changes in regulatory scenarios with their support for the genital warts market. The data is available for the historical period 2010 to 2019.

Competitive Landscape and Europe Genital Warts Market Share Analysis

Europe genital warts market competitive landscape provides details by a competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width, and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the company's focus related to the genital warts market.

The major companies providing the Europe genital warts are Bausch Health Companies Inc, Merck Sharpe & Dohme Corp., a subsidiary of Merck & Co., Inc, Taro Pharmaceutical Industries Ltd, Glenmark Pharmaceutical Inc., USA (a subsidiary of Glenmark Pharmaceuticals Ltd.), CryoIQ, GlaxoSmithKline plc, Cassiopea, Inc, BioNTech SE, Serum Institute of India Pvt. Ltd, Fotona, Orgenesis Inc and Perrigo Company plc

The strategic initiatives by market players along with new technological advancements for genital warts are bridging the gap for chronic wounds treatment. 

For instance,

  • In May, GlaxoSmithKline plc, Merck, Sharpe and Dohme, and Pfizer Inc. vaccines had received the approval from Centers for Disease Control and Prevention (CDC) to start distributing and providing vaccines to the citizens. The vaccine development and production would boost the immunization process among teenagers. It can deliver financial stability to GlaxoSmithKline plc, Merck, Sharpe and Dohme, and Pfizer Inc.

Collaboration, joint ventures, and other strategies by the market player are enhancing the company market in the Europe genital warts Market, which also provides the benefit for an organization to improve their offering for treatment Products.

Customization Available: Europe Genital Warts Market  

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market, and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.  


SKU-

LIST OF TABLES

TABLE 1 EUROPE GENITAL WARTS MARKET, PIPELINE ANALYSIS

TABLE 2 EUROPE GENITAL WARTS MARKET, BY MORPHOLOGY, 2019-2028 (USD MILLION)

TABLE 3 EUROPE CAULIFLOWER-LIKE IN GENITAL WARTS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 4 EUROPE SMOOTH PAPULAR IN GENITAL WARTS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 5 EUROPE KERATOTIC IN GENITAL WARTS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 6 EUROPE FLAT WARTS IN GENITAL WARTS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 7 EUROPE GENITAL WARTS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 8 EUROPE PREVENTION IN GENITAL WARTS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 9 EUROPE DIAGNOSTIC IN GENITAL WARTS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 10 EUROPE DIAGNOSTIC IN GENITAL WARTS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 11 EUROPE TREATMENT IN GENITAL WARTS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 12 EUROPE TREATMENT IN GENITAL WARTS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 13 EUROPE PHARMACOLOGICAL TREATMENT IN GENITAL WARTS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 14 EUROPE NON- PHARMACOLOGICAL TREATMENT IN GENITAL WARTS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 15 EUROPE TREATMENT IN GENITAL WARTS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 16 EUROPE GENITAL WARTS MARKET, BY CAUSE, 2019-2028 (USD MILLION)

TABLE 17 EUROPE HPV 6 IN GENITAL WARTS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 18 EUROPE HPV 11 IN GENITAL WARTS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 19 EUROPE OTHERS IN GENITAL WARTS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 20 EUROPE GENITAL WARTS MARKET, BY LOCATION, 2019-2028 (USD MILLION)

TABLE 21 EUROPE VULVA IN GENITAL WARTS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 22 EUROPE CERVIX UTERI IN GENITAL WARTS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 23 EUROPE URETHRA IN GENITAL WARTS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 24 EUROPE ANUS IN GENITAL WARTS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 25 EUROPE SCROTUM IN GENITAL WARTS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 26 EUROPE GENITAL WARTS MARKET, BY GENDER, 2019-2028 (USD MILLION)

TABLE 27 EUROPE FEMALE IN GENITAL WARTS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 28 EUROPE MALE IN GENITAL WARTS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 29 EUROPE GENITAL WARTS MARKET, BY DOSAGE, 2019-2028 (USD MILLION)

TABLE 30 EUROPE CREAM IN GENITAL WARTS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 31 EUROPE GEL IN GENITAL WARTS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 32 EUROPE OINTMENT IN GENITAL WARTS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 33 EUROPE INTRAMUSCULARLY IN GENITAL WARTS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 34 EUROPE OTHERS IN GENITAL WARTS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 35 EUROPE GENITAL WARTS MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 36 EUROPE HOSPITALS IN GENITAL WARTS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 37 EUROPE DIAGNOSTIC CENTERS IN GENITAL WARTS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 38 EUROPE SURGICAL CENTERS IN GENITAL WARTS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 39 EUROPE AMBULATORY SURGICAL CENTERS IN GENITAL WARTS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 40 EUROPE OTHERS IN GENITAL WARTS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 41 EUROPE GENITAL WARTS MARKET, BY DISTRIBUTION CHANNEL 2019-2028 (USD MILLION)

TABLE 42 EUROPE DIRECT TENDER IN GENITAL WARTS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 43 EUROPE PHARMACY STORES IN GENITAL WARTS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 44 EUROPE OTHERS IN GENITAL WARTS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 45 EUROPE GENITAL WARTS MARKET, BY COUNTRY, 2019-2028 (USD MILLION)

TABLE 46 EUROPE GENITAL WARTS MARKET, BY MORPHOLOGY, 2019-2028 (USD MILLION)

TABLE 47 EUROPE GENITAL WARTS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 48 EUROPE DIAGNOSTIC IN GENITAL WARTS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 49 EUROPE TREATMENT IN GENITAL WARTS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 50 EUROPE PHARMACOLOGICAL TREATMENT IN GENITAL WARTS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 51 EUROPE PREVENTION GENITAL WARTS MARKET, BY TREATMENT, 2019-2028 (USD MILLION)

TABLE 52 EUROPE GARDASIL GENITAL WARTS MARKET, BY COUNTRY, 2019-2028 (USD MILLION)

TABLE 53 EUROPE CERVARIX GENITAL WARTS MARKET, BY COUNTRY, 2019-2028 (USD MILLION)

TABLE 54 EUROPE NON-PHARMACOLOGICAL TREATMENT IN GENITAL WARTS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 55 EUROPE GENITAL WARTS MARKET, BY CAUSE, 2019-2028 (USD MILLION)

TABLE 56 EUROPE GENITAL WARTS MARKET, BY LOCATION, 2019-2028 (USD MILLION)

TABLE 57 EUROPE GENITAL WARTS MARKET, BY GENDER, 2019-2028 (USD MILLION)

TABLE 58 EUROPE GENITAL WARTS MARKET, BY DOSAGE, 2019-2028 (USD MILLION)

TABLE 59 EUROPE GENITAL WARTS MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 60 EUROPE GENITAL WARTS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 61 GERMANY GENITAL WARTS MARKET, BY MORPHOLOGY, 2019-2028 (USD MILLION)

TABLE 62 GERMANY GENITAL WARTS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 63 GERMANY DIAGNOSTIC IN GENITAL WARTS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 64 GERMANY TREATMENT IN GENITAL WARTS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 65 GERMANY PHARMACOLOGICAL TREATMENT IN GENITAL WARTS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 66 GERMANY GENITAL WARTS MARKET, BY TREATMENT, 2019-2028 (USD MILLION)

TABLE 67 GERMANY NON-PHARMACOLOGICAL TREATMENT IN GENITAL WARTS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 68 GERMANY GENITAL WARTS MARKET, BY CAUSE, 2019-2028 (USD MILLION)

TABLE 69 GERMANY GENITAL WARTS MARKET, BY LOCATION, 2019-2028 (USD MILLION)

TABLE 70 GERMANY GENITAL WARTS MARKET, BY GENDER, 2019-2028 (USD MILLION)

TABLE 71 GERMANY GENITAL WARTS MARKET, BY DOSAGE, 2019-2028 (USD MILLION)

TABLE 72 GERMANY GENITAL WARTS MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 73 GERMANY GENITAL WARTS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 74 FRANCE GENITAL WARTS MARKET, BY MORPHOLOGY, 2019-2028 (USD MILLION)

TABLE 75 FRANCE GENITAL WARTS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 76 FRANCE DIAGNOSTIC IN GENITAL WARTS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 77 FRANCE TREATMENT IN GENITAL WARTS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 78 FRANCE PHARMACOLOGICAL TREATMENT IN GENITAL WARTS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 79 FRANCE GENITAL WARTS MARKET, BY TREATMENT, 2019-2028 (USD MILLION)

TABLE 80 FRANCE TREATMENT IN GENITAL WARTS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 81 FRANCE GENITAL WARTS MARKET, BY CAUSE, 2019-2028 (USD MILLION)

TABLE 82 FRANCE GENITAL WARTS MARKET, BY LOCATION, 2019-2028 (USD MILLION)

TABLE 83 FRANCE GENITAL WARTS MARKET, BY GENDER, 2019-2028 (USD MILLION)

TABLE 84 FRANCE GENITAL WARTS MARKET, BY DOSAGE, 2019-2028 (USD MILLION)

TABLE 85 FRANCE GENITAL WARTS MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 86 FRANCE GENITAL WARTS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 87 U.K. GENITAL WARTS MARKET, BY MORPHOLOGY, 2019-2028 (USD MILLION)

TABLE 88 U.K. GENITAL WARTS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 89 U.K. DIAGNOSTICS IN GENITAL WARTS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 90 U.K. TREATMENT IN GENITAL WARTS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 91 U.K. PHARMACOLOGICAL TREATMENT IN GENITAL WARTS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 92 U.K. GENITAL WARTS MARKET, BY TREATMENT, 2019-2028 (USD MILLION)

TABLE 93 U.K. NON-PHARMACOLOGICAL TREATMENT IN GENITAL WARTS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 94 U.K. GENITAL WARTS MARKET, BY CAUSE, 2019-2028 (USD MILLION)

TABLE 95 U.K. GENITAL WARTS MARKET, BY LOCATION, 2019-2028 (USD MILLION)

TABLE 96 U.K. GENITAL WARTS MARKET, BY GENDER, 2019-2028 (USD MILLION)

TABLE 97 U.K. GENITAL WARTS MARKET, BY DOSAGE, 2019-2028 (USD MILLION)

TABLE 98 U.K. GENITAL WARTS MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 99 U.K. GENITAL WARTS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 100 ITALY GENITAL WARTS MARKET, BY MORPHOLOGY, 2019-2028 (USD MILLION)

TABLE 101 ITALY GENITAL WARTS MARKET, BY TYPE, 2019-2028, (USD MILLION)

TABLE 102 ITALY GENITAL WARTS MARKET, BY DIAGNOSTICS TYPE, 2019-2028, (USD MILLION)

TABLE 103 ITALY TREATMENT IN GENITAL WARTS MARKET, BY TYPE, 2019-2028, (USD MILLION)

TABLE 104 ITALY PHARMACOLOGICAL IN GENITAL WARTS MARKET, BY TREATMENT, 2019-2028, (USD MILLION)

TABLE 105 ITALY GENITAL WARTS MARKET, BY TREATMENT, 2019-2028, (USD MILLION)

TABLE 106 ITALY NON-PHARMACOLOGICAL TREATMENT IN GENITAL WARTS MARKET, BY TREATMENT, 2019-2028, (USD MILLION)

TABLE 107 ITALY GENITAL WARTS MARKET, BY CAUSE, 2019-2028, (USD MILLION)

TABLE 108 ITALY GENITAL WARTS MARKET, BY LOCATION, 2019-2028, (USD MILLION)

TABLE 109 ITALY GENITAL WARTS MARKET, BY GENDER, 2019-2028, (USD MILLION)

TABLE 110 ITALY GENITAL WARTS MARKET, BY DOSAGE, 2019-2028, (USD MILLION)

TABLE 111 ITALY GENITAL WARTS MARKET, BY END USER, 2019-2028, (USD MILLION)

TABLE 112 ITALY GENITAL WARTS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028, (USD MILLION)

TABLE 113 SPAIN EUROPE GENITAL WARTS MARKET, BY MORPHOLOGY, 2019-2028 (USD MILLION)

TABLE 114 SPAIN GENITAL WARTS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 115 SPAIN DIAGNOSTICS IN GENITAL WARTS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 116 SPAIN TREATMENT IN GENITAL WARTS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 117 SPAIN PHARMACOLOGICAL TREATMENT IN GENITAL WARTS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 118 SPAIN GENITAL WARTS MARKET, BY TREATMENT, 2019-2028 (USD MILLION)

TABLE 119 SPAIN NON-PHARMACOLOGICAL TREATMENT IN GENITAL WARTS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 120 SPAIN GENITAL WARTS MARKET, BY CAUSE, 2019-2028 (USD MILLION)

TABLE 121 SPAIN GENITAL WARTS MARKET, BY LOCATION, 2019-2028 (USD MILLION)

TABLE 122 SPAIN GENITAL WARTS MARKET, BY GENDER, 2019-2028 (USD MILLION)

TABLE 123 SPAIN GENITAL WARTS MARKET, BY DOSAGE, 2019-2028 (USD MILLION)

TABLE 124 SPAIN GENITAL WARTS MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 125 SPAIN GENITAL WARTS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 126 NETHERLANDS GENITAL WARTS MARKET, BY MORPHOLOGY, 2019-2028 (USD MILLION)

TABLE 127 NETHERLANDS GENITAL WARTS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 128 NETHERLANDS DIAGNOSTICS IN GENITAL WARTS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 129 NETHERLANDS TREATMENT IN GENITAL WARTS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 130 NETHERLANDS PHARMACOLOGICAL TREATMENT IN GENITAL WARTS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 131 NETHERLANDS GENITAL WARTS MARKET, BY TREATMENT, 2019-2028 (USD MILLION)

TABLE 132 NETHERLANDS NON-PHARMACOLOGICAL TREATMENT IN GENITAL WARTS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 133 NETHERLANDS GENITAL WARTS MARKET, BY CAUSE, 2019-2028 (USD MILLION)

TABLE 134 NETHERLANDS GENITAL WARTS MARKET, BY LOCATION, 2019-2028 (USD MILLION)

TABLE 135 NETHERLANDS GENITAL WARTS MARKET, BY GENDER, 2019-2028 (USD MILLION)

TABLE 136 NETHERLANDS GENITAL WARTS MARKET, BY DOSAGE, 2019-2028 (USD MILLION)

TABLE 137 NETHERLANDS GENITAL WARTS MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 138 NETHERLANDS GENITAL WARTS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 139 RUSSIA GENITAL WARTS MARKET, BY MORPHOLOGY, 2019-2028 (USD MILLION)

TABLE 140 RUSSIA GENITAL WARTS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 141 RUSSIA DIAGNOSTICS IN GENITAL WARTS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 142 RUSSIA TREATMENT IN GENITAL WARTS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 143 RUSSIA PHARMACOLOGICAL TREATMENT IN GENITAL WARTS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 144 RUSSIA GENITAL WARTS MARKET, BY TREATMENT, 2019-2028 (USD MILLION)

TABLE 145 RUSSIA NON-PHARMACOLOGICAL TREATMENT IN GENITAL WARTS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 146 RUSSIA GENITAL WARTS MARKET, BY CAUSE, 2019-2028 (USD MILLION)

TABLE 147 RUSSIA GENITAL WARTS MARKET, BY LOCATION, 2019-2028 (USD MILLION)

TABLE 148 RUSSIA GENITAL WARTS MARKET, BY GENDER, 2019-2028 (USD MILLION)

TABLE 149 RUSSIA GENITAL WARTS MARKET, BY DOSAGE, 2019-2028 (USD MILLION)

TABLE 150 RUSSIA GENITAL WARTS MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 151 RUSSIA GENITAL WARTS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 152 SWITZERLAND EUROPE GENITAL WARTS MARKET, BY MORPHOLOGY, 2019-2028 (USD MILLION)

TABLE 153 SWITZERLAND GENITAL WARTS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 154 SWITZERLAND DIAGNOSTICS IN GENITAL WARTS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 155 SWITZERLAND TREATMENT IN GENITAL WARTS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 156 SWITZERLAND PHARMACOLOGICAL TREATMENT IN GENITAL WARTS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 157 SWITZERLAND GENITAL WARTS MARKET, BY TREATMENT, 2019-2028 (USD MILLION)

TABLE 158 SWITZERLAND NON-PHARMACOLOGICAL TREATMENT IN GENITAL WARTS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 159 SWITZERLAND GENITAL WARTS MARKET, BY CAUSE, 2019-2028 (USD MILLION)

TABLE 160 SWITZERLAND GENITAL WARTS MARKET, BY LOCATION, 2019-2028 (USD MILLION)

TABLE 161 SWITZERLAND GENITAL WARTS MARKET, BY GENDER, 2019-2028 (USD MILLION)

TABLE 162 SWITZERLAND GENITAL WARTS MARKET, BY DOSAGE, 2019-2028 (USD MILLION)

TABLE 163 SWITZERLAND GENITAL WARTS MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 164 SWITZERLAND GENITAL WARTS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 165 TURKEY GENITAL WARTS MARKET, BY MORPHOLOGY, 2019-2028 (USD MILLION)

TABLE 166 TURKEY GENITAL WARTS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 167 TURKEY DIAGNOSTIC IN GENITAL WARTS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 168 TURKEY TREATMENT IN GENITAL WARTS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 169 TURKEY PHARMACOLOGICAL TREATMENT IN GENITAL WARTS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 170 TURKEY NON-PHARMACOLOGICAL TREATMENT IN GENITAL WARTS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 171 TURKEY GENITAL WARTS MARKET, BY TREATMENT, 2019-2028 (USD MILLION)

TABLE 172 TURKEY GENITAL WARTS MARKET, BY CAUSE, 2019-2028 (USD MILLION)

TABLE 173 TURKEY GENITAL WARTS MARKET, BY LOCATION, 2019-2028 (USD MILLION)

TABLE 174 TURKEY GENITAL WARTS MARKET, BY GENDER, 2019-2028 (USD MILLION)

TABLE 175 TURKEY GENITAL WARTS MARKET, BY DOSAGE, 2019-2028 (USD MILLION)

TABLE 176 TURKEY GENITAL WARTS MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 177 TURKEY GENITAL WARTS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 178 AUSTRIA GENITAL WARTS MARKET, BY MORPHOLOGY, 2019-2028 (USD MILLION)

TABLE 179 AUSTRIA GENITAL WARTS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 180 AUSTRIA DIAGNOSTIC IN GENITAL WARTS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 181 AUSTRIA TREATMENT IN GENITAL WARTS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 182 AUSTRIA PHARMACOLOGICAL TREATMENT IN GENITAL WARTS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 183 AUSTRIA GENITAL WARTS MARKET, BY TREATMENT, 2019-2028 (USD MILLION)

TABLE 184 AUSTRIA TREATMENT IN GENITAL WARTS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 185 AUSTRIA GENITAL WARTS MARKET, BY CAUSE, 2019-2028 (USD MILLION)

TABLE 186 AUSTRIA GENITAL WARTS MARKET, BY LOCATION, 2019-2028 (USD MILLION)

TABLE 187 AUSTRIA GENITAL WARTS MARKET, BY GENDER, 2019-2028 (USD MILLION)

TABLE 188 AUSTRIA GENITAL WARTS MARKET, BY DOSAGE, 2019-2028 (USD MILLION)

TABLE 189 AUSTRIA GENITAL WARTS MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 190 AUSTRIA GENITAL WARTS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 191 NORWAY GENITAL WARTS MARKET, BY MORPHOLOGY, 2019-2028 (USD MILLION)

TABLE 192 NORWAY GENITAL WARTS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 193 NORWAY DIAGNOSTIC IN GENITAL WARTS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 194 NORWAY TREATMENT IN GENITAL WARTS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 195 NORWAY PHARMACOLOGICAL TREATMENT IN GENITAL WARTS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 196 NORWAY GENITAL WARTS MARKET, BY TREATMENT, 2019-2028 (USD MILLION)

TABLE 197 NORWAY NON-PHARMACOLOGICAL TREATMENT IN GENITAL WARTS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 198 NORWAY GENITAL WARTS MARKET, BY CAUSE, 2019-2028 (USD MILLION)

TABLE 199 NORWAY GENITAL WARTS MARKET, BY LOCATION, 2019-2028 (USD MILLION)

TABLE 200 NORWAY GENITAL WARTS MARKET, BY GENDER, 2019-2028 (USD MILLION)

TABLE 201 NORWAY GENITAL WARTS MARKET, BY DOSAGE, 2019-2028 (USD MILLION)

TABLE 202 NORWAY GENITAL WARTS MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 203 NORWAY GENITAL WARTS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 204 HUNGARY GENITAL WARTS MARKET, BY MORPHOLOGY, 2019-2028 (USD MILLION)

TABLE 205 HUNGARY GENITAL WARTS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 206 HUNGARY DIAGNOSTIC IN GENITAL WARTS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 207 HUNGARY TREATMENT IN GENITAL WARTS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 208 HUNGARY PHARMACOLOGICAL TREATMENT IN GENITAL WARTS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 209 HUNGARY GENITAL WARTS MARKET, BY TREATMENT, 2019-2028 (USD MILLION)

TABLE 210 HUNGARY NON-PHARMACOLOGICAL TREATMENT IN GENITAL WARTS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 211 HUNGARY GENITAL WARTS MARKET, BY CAUSE, 2019-2028 (USD MILLION)

TABLE 212 HUNGARY GENITAL WARTS MARKET, BY LOCATION, 2019-2028 (USD MILLION)

TABLE 213 HUNGARY GENITAL WARTS MARKET, BY GENDER, 2019-2028 (USD MILLION)

TABLE 214 HUNGARY GENITAL WARTS MARKET, BY DOSAGE, 2019-2028 (USD MILLION)

TABLE 215 HUNGARY GENITAL WARTS MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 216 HUNGARY GENITAL WARTS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 217 LITHUANIA GENITAL WARTS MARKET, BY MORPHOLOGY, 2019-2028 (USD MILLION)

TABLE 218 LITHUANIA GENITAL WARTS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 219 LITHUANIA DIAGNOSTIC IN GENITAL WARTS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 220 LITHUANIA TREATMENT IN GENITAL WARTS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 221 LITHUANIA PHARMACOLOGICAL TREATMENT IN GENITAL WARTS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 222 LITHUANIA GENITAL WARTS MARKET, BY TREATMENT, 2019-2028 (USD MILLION)

TABLE 223 LITHUANIA NON-PHARMACOLOGICAL TREATMENT IN GENITAL WARTS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 224 LITHUANIA GENITAL WARTS MARKET, BY CAUSE, 2019-2028 (USD MILLION)

TABLE 225 LITHUANIA GENITAL WARTS MARKET, BY LOCATION, 2019-2028 (USD MILLION)

TABLE 226 LITHUANIA GENITAL WARTS MARKET, BY GENDER, 2019-2028 (USD MILLION)

TABLE 227 LITHUANIA GENITAL WARTS MARKET, BY DOSAGE, 2019-2028 (USD MILLION)

TABLE 228 LITHUANIA GENITAL WARTS MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 229 LITHUANIA GENITAL WARTS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 230 IRELAND GENITAL WARTS MARKET, BY MORPHOLOGY, 2019-2028 (USD MILLION)

TABLE 231 IRELAND GENITAL WARTS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 232 IRELAND DIAGNOSTIC IN GENITAL WARTS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 233 IRELAND TREATMENT IN GENITAL WARTS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 234 IRELAND PHARMACOLOGICAL TREATMENT IN GENITAL WARTS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 235 IRELAND GENITAL WARTS MARKET, BY TREATMENT, 2019-2028 (USD MILLION)

TABLE 236 IRELAND NON-PHARMACOLOGICAL TREATMENT IN GENITAL WARTS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 237 IRELAND GENITAL WARTS MARKET, BY CAUSE, 2019-2028 (USD MILLION)

TABLE 238 IRELAND GENITAL WARTS MARKET, BY LOCATION, 2019-2028 (USD MILLION)

TABLE 239 IRELAND GENITAL WARTS MARKET, BY GENDER, 2019-2028 (USD MILLION)

TABLE 240 IRELAND GENITAL WARTS MARKET, BY DOSAGE, 2019-2028 (USD MILLION)

TABLE 241 IRELAND GENITAL WARTS MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 242 IRELAND GENITAL WARTS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 243 POLAND GENITAL WARTS MARKET, BY MORPHOLOGY, 2019-2028 (USD MILLION)

TABLE 244 POLAND GENITAL WARTS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 245 POLAND DIAGNOSTIC IN GENITAL WARTS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 246 POLAND TREATMENT IN GENITAL WARTS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 247 POLAND PHARMACOLOGICAL TREATMENT IN GENITAL WARTS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 248 POLAND GENITAL WARTS MARKET, BY TREATMENT, 2019-2028 (USD MILLION)

TABLE 249 POLAND NON-PHARMACOLOGICAL TREATMENT IN GENITAL WARTS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 250 POLAND GENITAL WARTS MARKET, BY CAUSE, 2019-2028 (USD MILLION)

TABLE 251 POLAND GENITAL WARTS MARKET, BY LOCATION, 2019-2028 (USD MILLION)

TABLE 252 POLAND GENITAL WARTS MARKET, BY GENDER, 2019-2028 (USD MILLION)

TABLE 253 POLAND GENITAL WARTS MARKET, BY DOSAGE, 2019-2028 (USD MILLION)

TABLE 254 POLAND GENITAL WARTS MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 255 POLAND GENITAL WARTS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 256 REST OF EUROPE EUROPE GENITAL WARTS MARKET, BY MORPHOLOGY, 2019-2028 (USD MILLION)

 

CHOOSE LICENCE TYPE
  • 4200.00
  • 3500.00
  • 2000.00
  • 5500.00
  • 7500.00
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions